Longitudinal Electronic Health Records (EHRs)
OMOP CDM-structured, enriched with clinical outcomes and accompanied by raw files.
OmicsBank provides unparalleled access to multi-omic, clinical, and structured EHR from Asia and the Middle East, fuelling breakthroughs in drug discovery, precision medicine and clinical trials.
OmicsBank accelerates your life-sciences innovation with unmatched access to data and biospecimens at scale.
Patient, health, and multi-omic datasets for research, drug development, and clinical trials
Detailed therapeutic-area-specific collections:
Access comprehensive therapeutic datasets tailored to your research needs with complete patient journeys and longitudinal records.
Access diverse, structured, and analysis-ready data
OMOP CDM-structured, enriched with clinical outcomes and accompanied by raw files.
Digitized pathology slides and structured histopathology findings.
High-quality sequencing data supporting disease gene mapping and variant interpretation.
RNA expression profiles for discovery of molecular mechanisms.
Protein expression and quantification datasets.
Annotated radiology and diagnostic imaging datasets.
Access to raw biological materials including tissue samples, blood, and plasma with corresponding metadata.
We standardize data through the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) framework. Clients can request random samples from the data to be verified by both clinical professionals and data science experts before each data access request.
HIPAA and GDPR compliant process. Collaborations with HIPAA and GDPR specialists across the United States, Europe, and Asia, from whom an audit and certification can be obtained upon request.
We create a digital audit trail for consent (either taken on paper OR digital), ensuring complete transparency and regulatory compliance throughout the entire data collection process.
Patent-pending software for anonymization and de-identification designed to precisely identify and anonymize personal data in compliance with HIPAA, GDPR, and local/country-specific laws.
Leveraging data from diverse and populous regions unlocks unique benefits for healthcare AI advancement
A rare disease is uncommon in a single nation, but aggregating data from larger populations delivers meaningful insights at scale.
Capitalize on early insights into emerging healthcare markets.
Rich, diverse datasets essential for AI training, drug discovery, and clinical research.
Enhanced genetic diversity in data contributes significantly to robust and universally applicable healthcare solutions.
169 Madison Avenue,
STE 11133,
New York, NY 10016, USA
Phone: +1 (857) 654-2544
Email: info@omicsbank.com
Hours: 9AM-6PM EST
Monday - Friday